InvestorsHub Logo
Followers 6
Posts 2176
Boards Moderated 1
Alias Born 01/15/2019

Re: None

Saturday, 07/15/2023 9:59:23 PM

Saturday, July 15, 2023 9:59:23 PM

Post# of 21240
I finally got around to pulling the information. Overall New Mexico sales were down MoM 10%, but as IPS has mentioned, it looks like explosive growth regarding New Mexico Dispensary count (57 total; 41 R.Greenleaf and 16 Everest -- according to NM CROP).

With the NM dispensary count increasing by 24 stores, I am curious to see what their cash position will be sitting at when they release Q2-23 earnings. We can all see the challenges in both the CO and NM markets, so the Q2 ER is setting up to be a let down. I expect the "analysts" to only see/report the combination let down of both revenue and cash decline, without diving any deeper. If this happens, I am thinking that this could present a decent buying opportunity...but will be weighing my decision to add based on whether or not the company manages to find a way to maintain their gross profit and adjusted EBITDA margins.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHWZ News